美尚生態(300495.SZ)控股股東王迎燕擬減持不超3%股份
格隆匯11月1日丨美尚生態(300495.SZ)公佈,公司控股股東王迎燕計劃減持期間內擬減持不超過公司總股本3%的股份,即約2022.87萬股。其中,通過大宗交易方式減持的,自減持計劃公告之日起3個交易日之後的3個月內,減持股數不超過公司總股份的2%,即約1348.58萬股;通過集中競價方式減持的,自減持計劃公告日起15個交易日之後的3個月內,減持股數不超過公司總股份的1%,即約674.29萬股。若計劃減持期間公司有派息、送股、資本公積金轉增股本、配股等除權除息事項,減持股份數、股權比例將相應進行調整。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.